home / stock / adms / adms quote
Last: | $8.22 |
---|---|
Change Percent: | 0.74% |
Open: | $8.24 |
Close: | $8.22 |
High: | $8.25 |
Low: | $8.18 |
Volume: | 3,151,400 |
Last Trade Date Time: | 11/23/2021 04:55:24 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.22 | $8.24 | $8.22 | $8.25 | $8.18 | 3,151,400 | 11-23-2021 |
$8.16 | $8.16 | $8.16 | $8.21 | $8.15 | 1,047,168 | 11-22-2021 |
$8.16 | $8.17 | $8.16 | $8.19 | $8.15 | 348,528 | 11-19-2021 |
$8.17 | $8.18 | $8.17 | $8.21 | $8.17 | 1,259,865 | 11-18-2021 |
$8.2 | $8.15 | $8.2 | $8.25 | $8.145 | 775,726 | 11-17-2021 |
$8.15 | $8.13 | $8.15 | $8.2 | $8.13 | 625,216 | 11-16-2021 |
$8.13 | $8.17 | $8.13 | $8.17 | $8.13 | 348,050 | 11-15-2021 |
$8.2 | $8.14 | $8.2 | $8.2 | $8.11 | 1,499,583 | 11-12-2021 |
$8.14 | $8.16 | $8.14 | $8.18 | $8.14 | 458,488 | 11-11-2021 |
$8.16 | $8.14 | $8.16 | $8.16 | $8.13 | 373,745 | 11-10-2021 |
$8.15 | $8.17 | $8.15 | $8.18 | $8.14 | 426,175 | 11-09-2021 |
$8.18 | $8.16 | $8.18 | $8.2 | $8.16 | 721,477 | 11-08-2021 |
$8.2 | $8.17 | $8.2 | $8.2 | $8.15 | 558,091 | 11-05-2021 |
$8.18 | $8.17 | $8.18 | $8.2 | $8.12 | 716,245 | 11-04-2021 |
$8.23 | $8.15 | $8.23 | $8.24 | $8.14 | 1,145,237 | 11-03-2021 |
$8.17 | $8.15 | $8.17 | $8.19 | $8.15 | 426,844 | 11-02-2021 |
$8.16 | $8.12 | $8.16 | $8.24 | $8.11 | 351,283 | 11-01-2021 |
$8.11 | $8.09 | $8.11 | $8.14 | $8.09 | 434,527 | 10-29-2021 |
$8.12 | $8.08 | $8.12 | $8.13 | $8.065 | 635,475 | 10-28-2021 |
$8.1 | $8.06 | $8.1 | $8.13 | $8.03 | 1,253,251 | 10-27-2021 |
News, Short Squeeze, Breakout and More Instantly...
Adamas Pharmaceuticals Inc. Company Name:
ADMS Stock Symbol:
NASDAQ Market:
Adamas Pharmaceuticals Inc. Website:
Supernus Pharmaceuticals (NASDAQ: SUPN) recently announced that it's acquiring Adamas Pharmaceuticals (NASDAQ: ADMS) . In this Motley Fool Live video recorded on Oct. 13 , Motley Fool contributors Keith Speights and Brian Orelli discuss why Supernus' planned acq...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Adamas Pharmaceuticals, Inc. Announces Definitive Agreement to be Acquired by Supernus Pharmaceuticals, Inc” Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) surged ove...
Supernus Pharmaceuticals Inc ( NASDAQ: SUPN ) recently announced that it had entered a definitive contract to acquire Adamas Pharmaceuticals ( NASDAQ: ADMS ). Supernus is to purchase this company a tender offer that was worth about $8.10 per share. The aggregate was roug...